Novel ELISA protocol links pre-existing SARS-CoV-2 reactive antibodies with endemic coronavirus immunity and age and reveals improved serologic identification of acute COVID-19 via multi-parameter detection
Rachel R. Yuen, Dylan Steiner, Erika L. Smith, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Lillia A. Baird, Filiz Korkmaz, Patricia Urick, Manish Sagar, Jacob L. Berrigan, Suryaram Gummuluru, Ronald B. Corley, Karen Quillen, View ORCID ProfileAnna C. Belkina, Gustavo Mostoslavsky, Wenda Gao, Ian Rifkin, Amedeo J. Cappione III, Nina H. Lin, Yachana Kataria, Nahid Bhadelia, View ORCID ProfileJennifer E. Snyder-Cappione
doi: https://doi.org/10.1101/2020.09.15.20192765
Rachel R. Yuen
1Department of Microbiology; Boston University School of Medicine, Boston, MA, USA
Dylan Steiner
2PiBS Program, Boston University School of Medicine, Boston, MA, USA
Erika L. Smith
2PiBS Program, Boston University School of Medicine, Boston, MA, USA
Riley M.F. Pihl
3Flow Cytometry Core Facility, Boston University School of Medicine, Boston, MA, USA
Elizabeth Chavez
2PiBS Program, Boston University School of Medicine, Boston, MA, USA
Alex Olson
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Lillia A. Baird
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Filiz Korkmaz
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Patricia Urick
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Manish Sagar
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Jacob L. Berrigan
1Department of Microbiology; Boston University School of Medicine, Boston, MA, USA
Suryaram Gummuluru
1Department of Microbiology; Boston University School of Medicine, Boston, MA, USA
Ronald B. Corley
1Department of Microbiology; Boston University School of Medicine, Boston, MA, USA
5National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA
Karen Quillen
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Anna C. Belkina
3Flow Cytometry Core Facility, Boston University School of Medicine, Boston, MA, USA
6Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA
Gustavo Mostoslavsky
7Center for Regenerative Medicine, Boston University School of Medicine, Boston, MA, USA
Wenda Gao
8Antagen Pharmaceuticals, Boston, MA, USA
Ian Rifkin
5National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA
Amedeo J. Cappione III
9MilliporeSigma, Burlington, MA, USA
Nina H. Lin
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Yachana Kataria
6Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA
Nahid Bhadelia
4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
5National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA
Jennifer E. Snyder-Cappione
1Department of Microbiology; Boston University School of Medicine, Boston, MA, USA
3Flow Cytometry Core Facility, Boston University School of Medicine, Boston, MA, USA
Data Availability
The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.
Posted December 23, 2020.
Novel ELISA protocol links pre-existing SARS-CoV-2 reactive antibodies with endemic coronavirus immunity and age and reveals improved serologic identification of acute COVID-19 via multi-parameter detection
Rachel R. Yuen, Dylan Steiner, Erika L. Smith, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Lillia A. Baird, Filiz Korkmaz, Patricia Urick, Manish Sagar, Jacob L. Berrigan, Suryaram Gummuluru, Ronald B. Corley, Karen Quillen, Anna C. Belkina, Gustavo Mostoslavsky, Wenda Gao, Ian Rifkin, Amedeo J. Cappione III, Nina H. Lin, Yachana Kataria, Nahid Bhadelia, Jennifer E. Snyder-Cappione
medRxiv 2020.09.15.20192765; doi: https://doi.org/10.1101/2020.09.15.20192765
Novel ELISA protocol links pre-existing SARS-CoV-2 reactive antibodies with endemic coronavirus immunity and age and reveals improved serologic identification of acute COVID-19 via multi-parameter detection
Rachel R. Yuen, Dylan Steiner, Erika L. Smith, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson, Lillia A. Baird, Filiz Korkmaz, Patricia Urick, Manish Sagar, Jacob L. Berrigan, Suryaram Gummuluru, Ronald B. Corley, Karen Quillen, Anna C. Belkina, Gustavo Mostoslavsky, Wenda Gao, Ian Rifkin, Amedeo J. Cappione III, Nina H. Lin, Yachana Kataria, Nahid Bhadelia, Jennifer E. Snyder-Cappione
medRxiv 2020.09.15.20192765; doi: https://doi.org/10.1101/2020.09.15.20192765
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2826)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12523)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4403)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2835)
- Health Policy (1044)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4161)
- Nursing (220)
- Nutrition (615)
- Oncology (2189)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6742)
- Radiology and Imaging (1483)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (362)
- Surgery (471)
- Toxicology (57)
- Transplantation (198)
- Urology (173)